In 2011 was created Martlet, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The venture was found in Europe in United Kingdom.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the various public portfolio startups of the fund, we may underline Undo, PervasID, Repositive Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. We can highlight the next thriving fund investment areas, such as Biotechnology, Advanced Materials.
The increased amount of exits for fund were in 2019. The fund is constantly included in 2-6 deals per year. When the investment is from Martlet the average startup value is 5-10 millions dollars. Comparing to the other companies, this Martlet performs on 26 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund. Considering the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2016.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Martlet, startups are often financed by Cambridge Angels group, Cambridge Innovation Capital, Jaan Tallinn. The meaningful sponsors for the fund in investment in the same round are Parkwalk Advisors, IQ Capital, University of Cambridge Enterprise. In the next rounds fund is usually obtained by IQ Capital, Parkwalk Advisors, Longwall Venture Partners.
Funds with similar focus
Fund Name | Location |
Biomatics Capital Partners | Seattle, United States, Washington |
Changxiang Entertainment | Beijing, China, Shijingshan |
Chenhui Venture Partners | China, Shanghai |
FacePaint | New York, New York, United States |
Guava Capital | - |
Hitachi Systems | Japan, Tokyo |
Hokkaido Venture Capital | Hokkaido Prefecture, Japan, Sapporo |
Jianxin Capital | China, Shanghai |
Nazca Ventures | - |
OFS Capital Corporation | Illinois, Rolling Meadows, United States |
Sagene Tech Ventures | Norway, Oslo |
SEAG Ventures | Nashville, Tennessee, United States |
SLS Invest | - |
TELUS | British Columbia, Canada, Vancouver |
The Engine | Cambridge, Massachusetts, United States |
Wanxiang Blockchain | China, Shanghai |
Welsh, Carson, Anderson & Stowe | - |
Xinyu Beiqing Jishi Investment Center | China, Jiangxi, Xinyu |
Zhangshushu LvChangHongHeng Touzi GuanliZhongxin | China, Jiangxi, Yichun |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Infinitopes | $17M | 30 Apr 2024 | Oxford, Oxfordshire, United Kingdom | ||
Xampla | $7M | 30 Jan 2024 | Cambridge, England, United Kingdom | ||
OctaiPipe | $4M | 23 Jan 2024 | London, England, United Kingdom | ||
Spotta | $4M | 15 Dec 2023 | Cambridge, England, United Kingdom | ||
Nu Quantum | $9M | 02 Nov 2023 | Cambridge, England, United Kingdom | ||
Strolll Neurotechnology | $2M | 17 Oct 2023 | - | ||
Pencil Biosciences | $7M | 28 Sep 2023 | United Kingdom, England, United Kingdom | ||
RoboK | $2M | 29 Jun 2023 | Cambridge, England, United Kingdom | ||
PharmEnable | $8M | 22 May 2023 | Cambridge, England, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Infinitopes | $17M | 30 Apr 2024 | Oxford, Oxfordshire, United Kingdom | ||
Xampla | $7M | 30 Jan 2024 | Cambridge, England, United Kingdom | ||
OctaiPipe | $4M | 23 Jan 2024 | London, England, United Kingdom | ||
Spotta | $4M | 15 Dec 2023 | Cambridge, England, United Kingdom | ||
Nu Quantum | $9M | 02 Nov 2023 | Cambridge, England, United Kingdom | ||
Strolll Neurotechnology | $2M | 17 Oct 2023 | - | ||
Pencil Biosciences | $7M | 28 Sep 2023 | United Kingdom, England, United Kingdom | ||
RoboK | $2M | 29 Jun 2023 | Cambridge, England, United Kingdom | ||
PharmEnable | $8M | 22 May 2023 | Cambridge, England, United Kingdom |